After 30 days, major adverse cardiovascular events were 19.83%, heart failure was 18.18%, all-cause mortality was 5.79%.
Sau 30 ngày theo dõi, các biến cố tim mạch chính chiếm 19,83%, suy tim chiếm 18,18%, tử vong chiếm 5,79%.